PointState Capital’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,400
Closed -$917K 119
2021
Q3
$917K Sell
1,400
-200
-13% -$171K 0.02% 133
2021
Q2
$1.62M Buy
+1,600
New +$1.4M 0.03% 114

Other funds holding AGL

PointState Capital's AGL Position: Q4 2021 in Review

PointState Capital sold out of Agilon Health (AGL) in Q4 2021, closing a stake of 1,400 shares — an estimated $917K sold.

PointState Capital first reported a position in AGL in Q2 2021 and held it in 2 quarters. The position peaked at $1.62M in Q2 2021. 132 funds tracked by Wall St. Rank hold AGL as of Q4 2021.

  • PointState Capital reported no remaining Agilon Health position as of Q4 2021 after selling out during the quarter.
  • PointState Capital sold 1,400 Agilon Health shares in Q4 2021, an estimated $917K.
  • PointState Capital first reported a position in Agilon Health in Q2 2021 and held it in 2 quarters.
  • PointState Capital's Agilon Health position peaked at $1.62M in Q2 2021.
  • 132 funds tracked by Wall St. Rank held Agilon Health as of Q4 2021.

Based on PointState Capital's 13F filing for Q4 2021, filed 11 Feb 2022.